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Long-lasting forms of neuronal plasticity require de novo gene expression, but relatively little is known about the events that occur
genome-wide in response to activity in a neuronal network. Here, we unveil the gene expression programs initiated inmouse hippocam-
pal neurons in response to different stimuli and explore the contribution of four prominent plasticity-related transcription factors
(CREB, SRF, EGR1, and FOS) to these programs. Our study provides a comprehensive view of the intricate genetic networks and interac-
tions elicited by neuronal stimulation identifying hundreds of novel downstream targets, including novel stimulus-associated miRNAs
and candidate genes that may be differentially regulated at the exon/promoter level. Our analyses indicate that these four transcription
factors impinge on similar biological processes through primarily non-overlapping gene-expression programs. Meta-analysis of the
datasets generated in our study and comparison with publicly available transcriptomics data revealed the individual and collective
contribution of these transcription factors to different activity-driven genetic programs. In addition, both gain- and loss-of-function
experiments support a pivotal role for CREB inmembrane-to-nucleus signal transduction in neurons. Our data provide a novel resource
for researchers wanting to explore the genetic pathways associated with activity-regulated neuronal functions.
Introduction
External stimuli trigger highly specific transcriptional responses
in neurons through the activation of several dozens of plasticity-
related transcription factors (PRTFs) by different mechanisms,
such as phosphorylation, nuclear translocation, or transcrip-
tional induction (Herdegen and Leah, 1998). This activity-driven
gene expression mediates structural and functional changes that
affect the manner in which neurons process information and
respond to future stimuli, modifying the overall activity of neu-
ronal circuits (Flavell and Greenberg, 2008; Loebrich andNedivi,
2009). Previous attempts to characterize neuronal activity-driven
transcription and the regulon of specific PRTFs were limited by
the then available mouse genome annotation, the shortcomings
of in silico approaches for identifying target genes, and compara-
bility issues associated with the rapid development of microarray
technology. Furthermore, most studies have undertaken the
“candidate gene” approach, in which one or a few candidates
from a genome-wide screen are selected for additional study.
Although this is an effectivemanner of linking specific gene prod-
ucts with the investigated process and has allowed rapid progress
in the field of molecular neuroscience, it neglects the power and
potential of genome-wide approaches.
Here, we present data from transcriptomic experiments that
aim to provide understanding of neuronal function at a systems-
level scale (Dougherty and Geschwind, 2005; Geschwind and
Konopka, 2009; Valor and Barco, 2010). We first tackled the
transcriptional programs initiated in hippocampal neurons in
response to different kinds of stimuli through microarray-based
gene profiling. Next, we examined the gene programs down-
stream of four prominent PRTFs in the same system: (1) CREB, a
well-studied transcription factor (TF) that plays critical roles in
neuronal plasticity (Benito and Barco, 2010), survival, and differ-
entiation (Lonze andGinty, 2002) andwhose activity depends on
phosphorylation at specific serine residues by activity-regulated
protein kinases; (2) SRF, a TF also regulated by phosphorylation
that contributes to neuronal plasticity through the regulation of
cytoskeletal dynamics (Kno¨ll and Nordheim, 2009); (3) FOS, an
inducible TF widely used as a marker of neuronal activation,
although its specific function as well as its downstream gene pro-
gram are still poorly understood (Durchdewald et al., 2009); and
(4) EGR1, another TF whose expression is induced by neuronal
stimulation and by specific behavioral experiences (Bozon et al.,
2003). For CREB, this gain-of-function strategy was comple-
mented by gene profiling experiments with the strong inhibitor
of the CREB family of TFs A-CREB (Ahn et al., 1998). Meta-
analysis techniques revealed the relative contribution of these
four PRTFs to different activity-driven gene-expression pro-
grams, including those obtained in our gene profiling analysis of
stimuli response, and supported a key role forCREBas a signaling
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hub in the membrane-to-nucleus transduction pathway in neu-
rons. Overall, our study identifies hundreds of novel activity-
regulated genes in neurons and unveils important features of
activity-driven gene expression. The information can be accessed
through the searchable database NADtranscriptomics (http://in.
umh-csic.es/NADtranscriptomics/).
Materials andMethods
Lentiviral production. The DNA binding domain (DBD) of TFs CREB,
SRF, EGR1, and FOSwas fused with the acidic transactivation domain of
viral protein 16 (VP16) of herpes simplex virus (Flint and Shenk, 1997).
These chimeric constructs, as well as the coding sequence of A-CREB
(Ahn et al., 1998), were cloned into the Synapsin promoter-bearing len-
tiviral vector LenLox 3.7 (Gasco´n et al., 2008). Production of lentiviral
pseudovirions was performed as described by Gasco´n et al. (2008) with
minor modifications. Briefly,107 HEK293T cells were plated in 25 cm
dishes, incubated overnight, and transfected using the calcium phos-
phate method with a mixture of 20 g of transgene-bearing plasmid, 15
g of pCMV–8.9 plasmid containing the gag and pol viral genes and 10
g of pCAG–VSV-G plasmid encoding the protein G from vesicular
stomatitis virus (VSV-G) for pseudotyping. Media was replaced 4–6 h
after transfection to prevent cell toxicity. At 36–48 h after transfection,
cell supernatants were centrifuged at low speed (5 min, 2000 rpm) and
filtered to obtain a clear viral-containing solution. This solution was
ultracentrifuged at 25,000 rpm for 90 min to pellet viral particles. Viral
stocks were tittered by qRT-PCR (a standard curve was prepared in par-
allel using the lentiviral plasmid at known concentrations to estimate the
absolute number of viral genomes) and aliquoted for long-term storage
at80°C.Unconcentrated viral preparations regularly fell in the order of
108-109 particles/ml, from which it was estimated that the final titer in
viral stockswas1011 viral particles/ml.Given the possibility of contam-
inating genomic DNA and defective viral particles in the preparation
(Sastry et al., 2002), the effective titer is more likely at the 109 viral
particles/ml range.
Hippocampal neuron culture, infection, and chemical treatment. Pri-
mary hippocampal neurons were cultured in 24-well plates (Becton
Dickinson 353047) on 12 mm glass coverslips (VWR) coated with poly-
D-lysine (Sigma-Aldrich). Experimental animals were Swiss albino
mouse embryos at E17.5–E18.5 of either sex. Hippocampi were dissected
in ice-cold HBSS and pooled for trypsinization and homogenization.
Approximately 20–24 hippocampi from 10–12 embryos were pooled in
a 15ml tube per culture. After tissue homogenization, cells were counted
in aNeubauer chamber and seeded at a density of130,000 cells perwell.
Cells were incubated at 37°C and 0.5% CO2, and, after 2–3 h, plating
medium (DMEM supplemented with 10% FBS, 0.45% glucose, 2 mM
glutamine, and 100 U/ml to 100 g/ml penicillin/streptomycin) was re-
placed with definedmaintenancemedium (Neurobasal medium supple-
mented with B27, 2 mM glutamine, and 100 U/ml to 100 g/ml
penicillin/streptomycin). The day of plating was considered day in vitro 1
(1DIV). Neurons were incubated for at least 3 additional days (4DIV)
before they were used in any experiment. Primary hippocampal neurons
were infected at the times indicated by adding the necessary volume of
the concentrated viral preparation to achieve an effective multiplicity of
infection of 1–10, which provided a percentage of neuronal infection
close to 100%. The following concentrations were used for stimulation
experiments: bicuculline (bic) (Tocris Bioscience; 50M in DMSO) plus
4-AP (2.5 mM in H2O), forskolin (fsk) (Tocris Bioscience; 50 M in
DMSO), andBDNF (Sigma; 100 ng/ml inH2O). Tomake the stimulation
experiments more comparable with the constitutively active (ca) PRTF
experiments, all stimulations were performed on GFP-infected neurons.
Luciferase assays, Western blots, and immunohistochemistry. HEK293
cells were transfected with Lipofectamine (Invitrogen) according to the
instructions of the manufacturer. At 24 h after transfection, luciferase
activity was measured using the Dual Luciferase Assay kit (Promega).
Firefly luciferase was used as an activity indicator, and Renilla luciferase
was used as a normalizer. For Western blot, extraction buffer (50 mM
Tris-HCl, 150mMNaCl, 1mMEDTA, and 1%NP-40) containing protein
inhibitormix (Roche) was added to the cells, and extracts were sonicated
using a BioRuptor apparatus (Diagenode) with a 30 s ON–30 s OFF cycle
during 15 min. Equal amounts of extracted proteins were separated by
SDS-PAGE and transferred to a nitrocellulose membrane. Western blot
analyses were performed using ECL (PerkinElmer Life and Analytical
Sciences). The intensity of the protein bands was measured using Fuji-
film LAS-100 equipment and quantified usingQuantityOne 4.6 software
(Bio-Rad). For immunocytochemistry, cells were fixed in 4% para-
formaldehyde for 15 min at room temperature, washed with PBS, and
permeabilized with PBS containing 0.25% Triton X-100 for 10 min at
room temperature. Cells were incubated in the primary antibody
solution overnight at 4°C, and the secondary antibody incubation was
performed at room temperature during 1–3 h. Finally, nuclei were
counterstained with a 1 nM DAPI solution (Invitrogen). The primary
antibodies used in this study included -GFP (Aves Labs), -NeuN
(Millipore Bioscience Research Reagents), -GFAP (Sigma-Aldrich),
-VP16 from mouse (Santa Cruz Biotechnology; used in immunos-
tainings) and rabbit (Sigma-Aldrich; used for immunoblotting), and
-Flag–M2 (Sigma-Aldrich).
RNA extraction and qRT-PCR. Total RNA from hippocampal cultures
was extracted with the RNeasy mini kit (Qiagen) and reverse transcribed
to cDNA using the RevertAid First-Strand cDNA Synthesis kit (Fermen-
tas). qPCR was performed in an Applied Biosystems 7300 real-time PCR
unit using SYBR GreenER qPCR reagent mix (Invitrogen). Each inde-
pendent sample was assayed in duplicate and normalized using GAPDH
levels. All primer pairs were tested for efficiency, and their sequence is
available on request.
Microarray analysis. In microarrays experiments, a minimum of 106
cells (12 wells) were pooled per sample. RNA was extracted and puri-
fied as described and hybridized to Mouse Gene 1.0 ST gene chips from
Affymetrix. Five biological replicates were prepared for neurons infected
with the control VP16-only expressing lentivirus (LV), and three biolog-
ical replicates were prepared for all other conditions. Microarray data
were background corrected, normalized, summarized, and statistically
analyzed using R (http://www.r-project.org/; The R Development Core
Team) and Bioconductor (Gentleman et al., 2004). Quality control anal-
ysis was performed with the arrayQualityMetrics package (Kauffmann et
al., 2009). Vsn (variance stabilization normalization) (Huber et al., 2002)
was used for normalization and median polish from the affy package
(Gautier et al., 2004) for probe summarization. Moderated t tests from
the limma package (Smyth, 2005) were used for extracting statistically
significant genes by comparing with the appropriate control (VP16 for
lentiviral infection experiments andGFP-mock orGFP–DMSO for stim-
ulation experiments).
Bioinformatical analyses. Pearson’s correlations were calculated within R
with the“cor” function.We identifieddifferentially expressedprobeset iden-
tifications (representing groups of probesmapping to different exons of the
same gene) by applying the probeset-level annotation package in Biocon-
ductor for this particular platform (http://www.bioconductor.
org/packages/2.6/data/annotation/html/mogene10stprobeset.db.html; Ar-
thurLi).Probeset-level analysisofgeneexpressionwasperformedbyreading
in CEL files with the oligo package (Carvalho and Irizarry, 2010); normal-
ization and moderated t test calculations were performed using the same
packages mentioned above (VSN and limma packages). Candidate genes
with an interesting probeset-level regulation profile were shortlisted on the
basis of Z-test significance (see below, Statistical analysis), probeset fold
change, and probeset significance. Probeset fold change representations and
alignments to the genome and known transcripts were done with biomaRt
(Durinck et al., 2009b) and Genome Graphs (Durinck et al., 2009a). Heat
maps and hierarchical clustering were computed with the gplots package
(http://cran.r-project.org/web/packages/gplots/index.html; Gregory R.
Warnes). TopGO (http://www.bioconductor.org/packages/release/bioc/html/
topGO.html; Adrian Alexa and Jo¨rg Rahnenfuhrer) and GOstats (Falcon and
Gentleman, 2007) were used for Gene Ontology (GO) analysis. Because of the
inherent redundancy in the GOhierarchy, terms weremanually collapsed into
moregeneral expressions.Only termswithap0.01were considered for addi-
tional manual curation in all cases except in the TF comparison. To facilitate
direct comparisons in this case, the total number of GO terms to be manually
curated per conditionwas fixed based on the number of significant terms (p
0.05)inthemostrestrictivecondition(SRF-downregulatedgenes),andthesame
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numberoftermswasusedforalltheothergenelists.TheMammalianPhenotype
Ontology (Smith et al., 2005) annotationwasdownloaded fromtheMouseGe-
nome Informatics (MGI). FormiRNA target prediction analysis, target predic-
tions with good mirSVR score ( 0.1) for conserved and nonconserved
miRNAs were downloaded frommicroRNA.org. ThemirSVR is defined as an
empiricalmeasureof theprobabilityof agivenmRNAtobedownregulatedbya
given miRNA. As a complementary approach, the web-based tool Webgestalt
(Zhangetal.,2005a)wasusedtosearchforoverrepresentationofmiRNAtargets
within CREB-downregulated genes. Microarray identifiers (transcript cluster
identification numbers) were used as input, and four was selected as the mini-
mumnumberofgenespercategory.PSCAN(Zambelli et al., 2009)wasused for
predictions of TF binding sites in the promoter region (950/50) of selected
geneswiththepublicTRANSFACdatabaseasasourceforTFconsensusbinding
sites. Venny was used for representations of four-way Venn diagrams (http://
bioinfogp.cnb.csic.es/tools/venny/index.html; Juan Carlos Oliveros). Gene set
enrichmentanalysis (GSEA)(Subramanianetal., 2005)wasperformedwith the
stand-alone Java application and the Molecular Signature Database from the
BROAD Institute (Xie et al., 2005). Gene sets were taken from theMSigDB or
generated from the indicated literature. This dataset has been submitted to Ar-
rayExpress database and has received the accession number E-MEXP-3167. In
addition,our laboratorywebsiteprovides access to thegene listsdescribed in the
text and figures and to an online searchable database that allows the inter-
rogation of the dataset generated in this study (http://in.umh-csic.es/
NADtranscriptomics/).
Statistical analysis. Significance testing for qRT-PCR and luciferase
assays was done using t tests with the exception of VP16/GFP ratio ex-
pression analysis, in which a one-way ANOVA was performed to com-
pare the different groups. A two-way ANOVA was used to test main and
interaction effects of genotype and treatment in luciferase experiments
with A-CREB. All data are presented as mean  SEM. These statistical
analyses were performed with the SPSS software package. Significance
testing for probeset-level analysis of gene expression was performed by
first calculating Z-scores [defined as (xm)/SE, where x represents the
individual probeset fold change, m represents the average probeset fold
change for a given gene, and SE is the SE of themean probeset fold change
of a given gene] and using them to evaluate the probability of finding this
particular deviation from a normal distribution. Multiple testing adjust-
ments were performed by the method of Benjamini–Hochberg (Benja-
mini and Hochberg, 1995). For GO, MGI functional term, and miRNA
target prediction significance analysis, we calculated an enrichment score
based on the observed and expected number of genes per functional
category/number of predicted and observed targets per miRNA, and
statistical significance was assessed with Fisher’s exact test. In all cases,
only genes present in the array platform were considered as background.
For GSEA, statistical significance was assessed by permuting gene-set
labels according to the authors’ recommendation.
Results
Gene profiling of hippocampal cultures during different
kinds of neuronal stimulation
We used Mouse Gene ST version 1.0 Affymetrix microarrays to
identify genes induced in primary hippocampal cultures after
exposure to three different sorts of stimuli at a time in which the
neurons have extended an intricate network of processes and
synaptogenesis is ongoing (Papa et al., 1995): (1) bic comple-
mentedwith 4-AP, an establishedmodel of network disinhibition
that enhances network activity (Hardingham et al., 2002); (2) fsk,
an agonist of adenylyl cyclase that activates the cAMP pathway;
and (3) BDNF, a neurotrophin that triggers synaptic growth and
neuroprotection through activation of TrkB receptors. These
stimulations caused the regulation of hundreds of transcripts
(Fig. 1A,B; Table 1). Despite these protocols of chemical stimu-
lation being commonly used to induce synaptic plasticity in vitro
(e.g., fsk-induced LTP and BDNF-induced LTP), their compari-
son revealed a relatively low overlap between the genetic re-
sponses with 70–80% unique genes per condition (Fig. 1C).
Most overlapping genes between any pair of conditions were reg-
ulated in the same direction (Fig. 1D). The largest overlap was
found between fsk- and bic-dependent gene expression changes,
with 58 genes in common.Correlation analyses (Fig. 1E) revealed
a modest correlation between the BDNF and the fsk-induced
programs (Pearson’s correlation 0.19) but a stronger correla-
tion between fsk- and bic-dependent programs (Pearson’s corre-
lation 0.56), indicating that the transcriptional response could
be mediated in both cases by the same PRTFs. Remarkably, most
bic-downregulated genes were noncoding RNAs, including 12
miRNAs, 11 of which mapped into a large cluster on the distal
portion of chromosome 12 (Seitz et al., 2004; Kircher et al., 2008),
suggesting that they are jointly regulated (Fig. 1F). Downregu-
lated miRNAs were also part of the transcriptional response to
BDNF stimulation, suggesting a key contribution of miRNAs-
mediated mechanisms to activity-driven gene expression.
Dissecting activity-driven gene expression: gene regulation by
caCREB, caSRF, caEGR1, and caFOS
To investigate the contribution of specific TFs to these activity-
driven gene programs, we used a gain-of-function approach
based on lentiviral gene delivery of constitutively active variants
of four prominent PRTFs: CREB, SRF, EGR1, and FOS.With this
approach, we did not intend to reproduce the natural transcrip-
tional programs regulated by these TFs but to identify the gene
sets capable of responding to these TF in hippocampal neurons.
The caPRTFs were constructed by fusing the DBD of each TF
to the acidic transactivation domain VP16 (Fig. 2A). The activity
of these chimeric proteinswas first assessed inHEK293 cells using
luciferase reporter plasmids specific for each TF (Fig. 2B). Pseu-
doviruses infected primary hippocampal cultures from E17.5
mouse embryos very efficiently. Six days after infection (DINF),
transgenic expression was maximal without apparent effect on
cell viability (Fig. 2C). The chimeric PRTFs were coexpressed
with EGFP in 98% of the neurons, whereas the less abundant
glial cells (GFAP) did not express the transgenic proteins (Fig.
2D). qRT-PCR assays using primers for VP16 (Fig. 2E) and
Western blots (Fig. 2F) and immunocytochemistry analyses (Fig.
2G) using a VP16-specific antibody confirmed the expression
and nuclear localization of the chimeric constructs.
For gene profiling, total RNA was extracted from cultures
infected with the four caPRTF-expressing LV and with two con-
trol viruses expressing only EGFP or coexpressing EGFP and the
VP16 domain alone, and hybridized with Mouse Gene ST ver-
sion 1.0 microarrays. Expression of caCREB caused a dramatic
change, affecting10% of the transcriptome (2940 differentially
expressed transcripts corresponding to 2680 annotated genes),
whereas the other caPRTFs had a more modest effect on gene
expression, with 192, 85, and 276 differentially expressed genes
for caSRF, caEGR1, and caFOS, respectively (Fig. 3A,B; Table 1).
We observed a strong bias toward upregulation for each of the
four caPRTFs when only themost affected genes were considered
(Fig. 3B), as it may be expected from the expression of constitu-
tively active transcriptional activators. These lists contain both
previously identified target genes (e.g., Fos, Bdnf, Vgf, Pdyn, Sst,
and several members of theMHC class I for CREB;Arc,Tgln, and
all members of the Egr family for SRF; Rrad,Nab1, andNab2 for
EGR1; and Npy and Bdnf for FOS) and a large number of novel
target genes. We validated some of these changes by qRT-PCR in
independent samples (Fig. 3C). Importantly, there was no single
gene differentially expressed by these criteria between the two
control conditions (EGFP and VP16 viruses), indicating that
VP16 expression by itself had no effect on transcription.
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In addition to the conventional gene-level analysis, we per-
formed an exon-level differential expression analysis (for details,
see Materials and Methods) that identified a large number of
differentially expressed probeset identifications. These included a
strong increase for the probesetmapping into theDBD sequences
present in the lentiviral constructs (Fig. 4A), which represents a
valuable positive control. Among the candidate genes for differ-
ential promoter/exon usage, we found Bdnf, a gene withmultiple
internal promoters (Aid et al., 2007) for which we confirmed the
preferential usage of promoter I over promoter IV by caCREB
(Barco et al., 2005; Viosca et al., 2009) (Fig. 4B). In contrast, but
in agreement with previous reports of activity-dependent usage
of Bdnf promoters (Metsis et al., 1993; Tao et al., 1998), bic and,
to a lesser extent, fsk regulate Bdnf expression through both pro-
moters (Fig. 4B). Other relevant examples are Crem, whose anal-
ysis at the probeset level demonstrated the specific activation by
caCREB and fsk of the internal CRE-bearing promoter that drives
the expression of the inducible cAMP early repressor (ICER)
protein (Borlikova andEndo, 2009) (Fig. 4C) andHomer1, whose
short isoformHomer1a that functions as an inducible dominant-
negative form (Brakeman et al., 1997), is specifically regulated by
bic and more modestly by caCREB and fsk (Fig. 4D).
Given that the transcriptional changes downstream of ca-
CREB are much broader than those for the other caPRTFs, we
analyzed samples from caCREB-expressing neurons at an earlier
time after infection (10DIV, but only 3DINF).Wemight expect a
reduction in the number of changes after a shorter expression of
the transgene. However, we found that the gene profiles at 3 and
6DINFwere similar (Fig. 5A) andhighly correlated (Fig. 5B; 2405
and 2970 differentially expressed genes at, respectively, 3DINF
and 6DINF; 82.3% of genes regulated in the same direction at
both time points; Pearson’s correlation  0.71, p  1016).
k-means clustering indicates that, on average, the transcriptional
changes have reached a plateau 3DINF (Fig. 5C). Themajor func-
tional categories represented by genes differentially expressed at
3DINF and 6DINF (10% of total) corresponded to general
biological processes, including “metabolism,” “development,”
“transport,” and “cell communication” (result not shown), likely
reflecting the modulatory homeostatic cell response triggered by
sustained caCREB expression. These results indicate that the
larger gene expression program elicited by caCREB expression
genuinely reflects its larger potential to alter the transcriptional
status of the neuron and support a central role for CREB in the
molecular pathways linking activity and transcription.
Direct and indirect targets of caPRTFs
Three computational analyses indicated that the lists of caPRTF-
upregulated genes were highly and specifically enriched for direct
targets. First, the in silico prediction tool PSCAN (Zambelli et al.,
2009), which searches for TF consensus binding sequences in
promoter regions, revealed a significant enrichment for CRE,
SRE (serum response element), KRE (Krox/Egr regulatory ele-
Figure 1. Comparison of stimulus-driven profiles. A, The heat map illustrates the differential expression of hundreds of genes during neuronal stimulation with different compounds. We
stimulated the cultures with bic, fsk, and BDNF for 1, 18, and 48 h, respectively, based on previous literature and on preliminary qRT-PCR analyses (data not shown). B, Panels illustrate the
distribution of gene expression changes induced by different treatments. Genes are separately ordered for upregulation and downregulation frommost to least changed based on their absolute fold
change, and each gene is plotted as a separate entity on the x-axis with the corresponding fold change represented on the y-axis. Upregulations dominated in the response to bic and fsk, whereas
in the case of BDNF, downregulations and upregulations were balanced. The total number of genes affected is also indicated in the graphs. C, Venn diagram showing the number of genes in the
intersectionbetween thedifferentgene lists. Thenumbers inparentheses showthepercentageofuniquegenesper condition.D, Bar charts representing the specific percentageof overlappinggenes
between each pair of conditions, specifyingwhether commongenes change in the same (“Coherent”) or opposite (“Reversed”) directions. E, The correlation heatmap shows a significant correlation
betweenbic- and fsk-dependent gene expression programs ( p 0.001). F, Activity-regulatedmiRNAs. Note that both BDNF andbic cause a number ofmiRNAdownregulations. # indicates that the
specified miRNA belongs to the cluster of miRNAs located on chromosome 12.
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ment), and AP-1 sites within the promoter region of caCREB,
caSRF, caEGR1, and caFOS-upregulated genes, respectively, but
not for downregulated genes (Fig. 6A). KRE sites, similar to GC
boxes, were found associated with both upregulations and down-
regulations in the caCREB, caSRF, and caFOS regulons but spe-
cifically and more strongly enriched in the promoter region of
EGR1-upregulated genes. Second, GSEA (Subramanian et al.,
2005) revealed a very highly significant accumulation of genes
bearing the corresponding DNAmotif at the top of each gene list
(data not shown). Third, we took advantage of the available
genome-wide occupancy data generated in cortical neurons for
CREB and SRF (Kim et al., 2010) to compare TF bindingwith our
TF-regulated gene lists. We found a greater overlap between the
occupancy data and caCREB/caSRF-upregulated genes than for
downregulated genes (Fig. 6B).
These results also suggest that the genes downregulated in our
lists are more likely to be indirect targets of PRTF overactivation.
Transcript-level repression is particularly extensive in the case of
caCREB (Fig. 3A,B). Interestingly, we noticed the presence of a
number of upregulatedmiRNAs among caCREB-regulated tran-
scripts, including miR134 and miR132/212, which have been re-
cently associated with CREB and neuronal plasticity (Vo et al.,
2005;Mazie`re and Enright, 2007;Wayman et al., 2008; Gao et al.,
2010; Hansen et al., 2010; Impey et al., 2010; Lambert et al., 2010;
Remenyi et al., 2010). Notably, the bioinformatic tool formiRNA
target predictionMiRanda (Enright et al., 2003; Betel et al., 2008)
detected a significant enrichment of predicted miRNA targets
within CREB-downregulated genes (Fig. 6C), suggesting that
CREB-dependent miRNA induction may constitute an impor-
tant regulatory mechanism of the genetic response to this TF.
Similar results were obtained with WebGestalt (Zhang et al.,
2005a). Because a single miRNA can potentially target many dif-
ferent transcripts through degradation/stability mechanisms
(Guo et al., 2010), a substantial part of the broad transcriptional
repression program observed during caCREB expression could
be mediated through this mechanism.
Comparison of caPRTF-dependent gene programs and
functional analysis
An important aspect of our study in contrast with previously
available datasets is the comparability between the different con-
ditions, which allowedus to quantitatively juxtapose the caCREB,
caSRF, caEGR1, and caFOS-dependent changes. Direct compar-
isons between the programs revealed a large percentage of
caCREB-regulated genes unique to this TF (90%), whereas
65% of the caSRF-, caEGR1-, and caFOS-regulated genes were
responsive to more than one TF (Fig. 6D). The largest overlap
was found between the caCREB and caFOS lists, in agreement
with FOS being downstream of CREB. In all cases, most coinci-
dent genes were regulated in the same direction in any pair of
conditions (60–85%; data not shown). To facilitate comparisons
between the different profiles even while the number of caCREB-
responsive genes is much larger than for the other caPRTFs, we
limited the comparison to the top 100 changes per TF. This re-
vealed a similar percentage of exclusive changes (75%) for each
TF and limited overlap between the CREB and FOS regulon and
between the SRF and both the EGR1 and FOS regulons, consis-
tent with the whole transcriptome comparison level (data not
shown). The idiosyncrasy of TF-specific signatures is clearly illus-
trated by a clustering heat map of genes upregulated in at least
one condition (Fig. 6E, top). In contrast, the same representation
for downregulated genes showed less divergence, suggesting that
some downregulations may be part of a common homeostatic
genetic program (Fig. 6E, bottom).
In addition to the comparison of transcriptional profiles,
we also performed a comparative analysis of functional terms
Table 1. Most affected genes (first decile) in each condition
Bicuculine (366/265) Up (12.4-2.6): Fosb, Nr4a2, Npas4, Cyr61, Nr4a1, Fos, Dusp1, Arc, Btg2, Gadd45g, Gadd45b, Ptgs2, Fbxo33, Klf4, Snhg1 4	, Egr2, Ier2, Spty2d1, Egr1, Egr4, Tiparp, Hspa8 2	,
Dusp6, Junb, Atf3, Sap18, Maff, Jun
Down: None
Forskolin (518/500) Up (7.0-2.0): Nr4a1, Npas4, Fos, Cnn1, Nr4a2, Dusp1, Ptgs2, Slc17a6, Fosb, Vgf, Peg10, Rorb, Arc, Sik1, Fbln5, Srxn1, Gem, Stc1, Tac1, Egr1, Sat1, Plat, Nap1l5, Scg2, Pcsk1,
Dio2, Pros1, Htr2c, Siah3, Ptp4a1, Per1, Gna14, Ppp1r3c, Ier3, S1pr3, Pcdh11x, Ptprn, Sst, Nfil3, Gadd45g, Ecm1, Zhx2, Npy, Mmp3, Slc7a11
Down (2.5-2.0): Txnip, Mfge8, Cmtm5, Thrsp, Ndp, Hapln1, Aldoc
BDNF (298/223) Up (4.2-2.2): Npy, Tfrc, Pde1a, Dusp6, Sostdc1, Tmem45a, Nmb, Dusp4, Vgf, Sema3e
Down (3.7-2.0): Rpl13, Ubb, Rpl37a, Rps23, Rpl23a, Ftl1, Calb2, Malat1, LOC380994, Tmed2, Snord116, Atp5g2, Rpl35a
caCREB (2940/2680) Up (37.5-2.1): Dgkk, Nr4a2, Crhbp, Sv2c, Mcam, Fos, Pcdh11x, Nr4a1, Tinf2, Dusp1, Rnh1, Lcn2, Vgf, Taf13, Fosb, Nptx2, Penk, Pcsk1, H2-D1, Ebp, Cd68, Aloxe3, Cyr61, Ptgs2,
Crisp1, Gpr83, Slc17a6, Nap1l5, Galr1, Cnn1, H2-T22, H2-K1, Rbp4, Stac2, Sult2b1, Hsd11b1, Taf13, Atf3, Tac1, Pno, Sstr1, Ecel1, Npy, Tmem22, Trp53inp2, H2-T9, Rasgrf1,
Gad2, Sik1, Gpr3, Tpm4, D10Bwg1379e, Nfil3, Spock3, Pde1c, Fgl2, Gaa, Cgref1, Igsf10, Asphd1, Trpc6, Gadd45g, EG547347, Emd, Gadd45b, Cdh13, Sik3, Kdelr3, Omg,
Igsf10, Htr2a, Gls, Tceal6, Per1, Ssr4, Mfsd2a, Tpm4, Dgka, Gfra1, Cdkn1a, Tpt1, H2-Ab1, Tgif1, Ptprn, Frat1, H2-Q7, Prcp, Npas4, Wdr90, Pcna, Wbp5, Relt, Heca, Bcap29,
Sorcs3, Igsf9b, Dom3z, Slc32a1, Scg2, Polr2a, Gla, Slc18a2, Fam65b, Ypel4, Gdf11, Cyfip2, Ppp1r15a, Tceal3, Crh, Kcnc4, Srxn1, Adra1a, Trafd1, Pcna, Pam, Sst, Spag4,
Ccbl1, Fgf15, Sik2, Impact, Gpnmb, Rem2, Irf7, Cabp1, Cpeb1, Tpt1p, Cda, Csrnp1, S1pr3, Ache, Fam46a, Dub2a, Ehd4, Rnft1, Ghsr, Bdnf, Bpil2, Gal, Ccnd1
Down (6.7-2.1): Crym. Hpca, Lsm11, D0H4S114, Socs2, Lmo1, Calb2, Rerg, Cdh8, Dcx, Itgbl1, Ssbp2, St6galnac5, Gabra5, Ccnjl, Gpr12, Pcdh19, Tacr3, E130309F12Rik,
Bhlhe22, Camkv, Lypd6, Pvrl3, Nkain2, Tmem74, Klf7, Robo1, Plxnc1, Scn3b, Cdk14, Ntsr1, Caln1, Camkk2, Pgm2l1, Nrgn, Smpd3, Abca8a, Fam19a1, Lpl, Stmn1, Camk4,
LOC100043371, Rprm, Kctd4, 9030425E11Rik. Akt3, Fgf13, Nrp1, Cdh11, Hpcal1, Runx1t1, Sphkap, Cxcr4, Rbmx, Grik2, Sms, Rras2, Neo1, Crim1, Cdk19, Zfp238, Tmeff2,
Pcdh20. Sms, Fam5b, Myo1b, Strbp, Ptprr, Atp2b4, Aqp11, Cadps2, Tgfbr1, Ccdc85a, Cabp7, Neurod1, Ctnna2, Dok4, Rspo2, Slc6a11, Cdh10, Zdhhc23, Acvr2a, Car10,
Hpcal1, Kcnd2, Nrp2, Xkr4, Brd9, Trps1, Kcnip2, Ypel1, Cacna2d1, Mctp1, Mdga1, Plcxd2, Gm16476, Hn1, D430041D05Rik, Lmo3, Ralyl, Plxdc2, Arl15, Gnal, Scarna17,
Mgat4c, Erc2, Sh3kbp1, Coch, Mtss1, Neurl1B, Rac3, Grm5, Ak4, Arhgap33, 4930506M07Rik, Sema4a, Edil3, Fam73a, Fam188a, Syn2. Zim1, Srd5a1, Narf, Camk1d, Capn5,
Gpr63, Sema7a, Slc6a1, C77370, Gria3, Serpini1, Crmp1, Mvd, Neurod6, Bnip3, Marcksl1, Serinc5, Plxna2 Slc8a2, Ptprd
caSRF (204/192) Up (4.2-2.1): Pcp4l1, Abca8a, Net1, A2m, Sostdc1, Tagln, Egr4, Clrn1, Egr2, Gch1, Ptgr1, Nppa, Arc, Egr1, Figf
Down (2.5-2.1): Lpl, Neurod6, Tmem74, Cpm, C1ql3
caEGR1 (89/85) Up (22.0-2.8): Peg10, Rrad, Nab2, Baiap2, Sv2c, Pcsk2, Kcnt1, Tiam1, Ufsp1
Down: None
caFOS (297/275) Up (7.3-2.0): Pcdh11, Sema3e, S100a10, Met, Kitl, Nptx2, Sema3a, Col6a1, Npy, Tac1, Tacr1, Ptchd1, Cd68, Ociad2, Sult2b1, St8sia5, Kirrel3, Rgs4, Bdnf, Col18a1, Ptchd1
Down (2.6-2.0): Fam19a1, Lpl. Shisa6, Lypd6, Ccnjl, Pcdh19, Chodl, Rpl39, Nr3c2
In the first column, the number of TCID/annotated genes is shown in parentheses. In the second column, the rank of fold changes (FC) is indicated in parentheses. Somegeneswere represented formore than one TCID in the list, such as Snhg1
in the bicuculine list, and that number is shown between brackets. Notice the asymmetric distribution of upregulation and downregulation in the bic, fsk, caSRF, caEGR1 and caFOS lists.
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associated with the different caPRTF-responsive profiles. We
first examined the Mammalian Phenotype Ontology, a data-
base that provides disease-related phenotypic annotations for
mouse and rat genes in a hierarchical format (Smith et al.,
2005). Notably, we found a prominent representation of ner-
vous system development terms and a striking enrichment of
cognitive/neurological disorder terms associated with all four
PRTFs, with a particular representation of learning-disorder-
associated terms (Fig. 6F). We also analyzed functional en-
richment based on the GO database. This analysis revealed
that, although some general terms were enriched for all
caPRTFs, they were represented by different molecular enti-
ties/pathways for each TF (Table 2). Thus, for example, the
category “signaling pathways and transduction” was enriched
for all TFs, but it was represented by “BMP-mediated signal-
ing” in the case of caSRF and “neuropeptide-mediated signal-
ing” for caCREB. Despite the commonalities, we also found
certain specific terms associated with each TF [e.g., “cytoskel-
etal process” within SRF-upregulated genes (Kno¨ll and Nord-
heim, 2009), “antigen presentation/immune response” within
CREB-upregulated genes (Barco et al., 2005), and “learning
and memory” and “cell death regulation” within FOS-
regulated genes (Shaulian and Karin, 2002)]. This, together
with the TF-specific signatures illustrated in Figure 6E, sug-
gests that, whereas all four PRTFs impinge on similar cellular
functions, they do so through distinct molecular pathways.
Meta-analysis of activity-driven and caPRTF-dependent
gene profiles
We next explored the differential contribution of the four
caPRTFs investigated here to the stimulation-driven pro-
grams. The combination of the transcription programs asso-
ciated with each of the four caPRTFs accounted for40–50%
of the different stimulation paradigms (Fig. 7A), with CREB
being the major contributor to the three activity-dependent
programs (Fig. 7B). This was not entirely unexpected consid-
ering the larger size of the CREB regulon. To more precisely
define the contribution of the different TFs to activity-driven
gene expression, we generated “coverage plots” in which we
represent the percentage of genes covered by each caPRTF
considering stimulus-responsive genes above a certain fold
change within upregulations of the stimulus-driven transcrip-
tional programs (Fig. 7C). This representation clearly illus-
trates the hegemony of CREB in fsk-associated changes,
Figure 2. Infection of hippocampal cultures by caPRTFs-expressing LV. A, Scheme of lentiviral backbone, cloning sites, and caPRTF constructs. LTR, Long-termination repeats; SynP, synapsin
promoter; WPRE, woodchunk hepatitis virus post-transcriptional regulatory element. B, The different caPRTFs activate the corresponding luciferase reporter plasmids in HEK293 cells. The number
of reporter sites in each plasmid is indicated. **p  0.01, ***p  0.001, t test (n  7–10 per condition). C, Immunocytochemistry of hippocampal neurons infected with the different
caPRTF-expressing and control LV (10DIV/6DINF) using anti-GFP antibody. GFP expressionwas detectable at 3DINF by direct fluorescence and became progressively stronger, reaching a plateau by
6DINF (results not shown).D, Hippocampal neurons infectedwith VP16-only lentiviral particles were stained for GFP, NeuN, and GFAP. Green fluorescence shows the colocalization of EGFPwith the
neuronal marker NeuN and no colocalization with the astrocytic marker GFAP. The same result was obtained with all the caPRTF-expressing LVs (results not shown). E, qRT-PCR demonstrates
comparable VP16/GFP expression ratios for all caPRTF viruses with the exception of FOS, which is expressed slightly less efficiently (n 6 per condition). ***p 0.01, one-way ANOVA (F(5,30)
25.692) plus Tukey’s post hoc test in the comparison with GFP-only control; &p 0.01, Tukey’s post hoc test in the comparison with VP16-only control. F, Western blot with samples from infected
cultured hippocampal neurons and transfected HEK293 cultures. Bars on the left indicate the molecular weight in kilodaltons. Asterisks and arrowheads label the transgenic bands. G, Anti-VP16
immunocytochemistry demonstrates the nuclear expression of chimeric TFs, as exemplified by VP16–CREB. Colocalized pixels are shown inwhite (right). Bars represent average SEM. Scale bar,
10m.
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especially when only the strongest changes (right part of the
curve) are considered. This analysis also revealed an unex-
pected relevance of FOS in BDNF-dependent transcription
and the substantial contribution of both CREB and SRF to
bic-dependent transcription (Fig. 7C). Pairwise correlation
analyses, although modest, are in agreement with these obser-
vations (Fig. 7D).
To gain additional insight into the role of these four PRTFs in
activity-dependent transcription, we reanalyzed previous neuro-
nal activity profiling experiments using GSEA. This computa-
tional method can effectively address comparability issues
between different platforms and filtering criteria by making use
of the information of the complete dataset (Ioannidis et al., 2009;
Kauffmann et al., 2009). In addition to the gene profiles in re-
Figure 3. Overview of the CREB, SRF, EGR1, and FOS regulons. A, Hierarchical cluster of PRTF-dependent gene expression changes. B, The distribution of all PRTF-responsive genes as described
for Figure 1B. Bars below the distribution plots refer to the percentage of upregulations and downregulations considering only the top 100 genes per condition. Note that, because caEGR1 only
controls 85 genes, the analysis is limited to this number. C, Some known and novel candidates were selected for validation on an independent set of samples by qRT-PCR. *p 0.05, **p 0.01,
***p 0.001, t test (n 3 per condition). Error bars represent average SEM.
Figure 4. Probeset-level analysis of caPRTF-dependent gene expression.A, Increased signal for the specific probesetmapping into the lentiviral construct. EGR1 is not shown because the DBD of
this TF is represented by only 2 of 13 probes in a single probe set, precluding this type of analysis.B, BDNF is regulated by CREB preferentially via its promoter I (Pr. I, Prom I), whereas bic and fsk can
also regulate its expression through promoter IV (Pr. IV, Prom IV). Left, Yellow boxes represent the exon structure of the gene provided by Ensembl. The location of promoters I and IV, as well as CRE
sites, are indicated. Each measurement on the array is separated in the graph by a gray vertical line. Blue lines point to the corresponding mapping. The arrow above indicates the sense of
transcription. Right, qRT-PCR validation of differential promoter usage by CREB. *p 0.05, t test (n 3 per condition) C, Stimulationwith fsk and caCREB expression causes a specific upregulation
of ICER transcripts (indicated as a gray box). The location of internal promoter CRE sites is also indicated. The regulation of ICER by caCREB was validated by qRT-PCR with ICER-specific primers in
independent samples (n 3 per condition) andwith an ICER-promoter luciferase reporter in cotransfected HEK293 cells (n 6 per condition). ***p 0.001, t test.D, bic and fsk stimulations and
caCREB expression cause the specific upregulation of the short isoform Homer1a (indicated as a gray box).
Benito et al. • Dissecting Activity-Driven Gene Expression J. Neurosci., December 14, 2011 • 31(50):18237–18250 • 18243
sponse to different chemical stimuli presented above, we col-
lected five studies in which different types of stimulations were
used, including LTP and chemical stimulation paradigms, for
comparison with our data (Hansen et al., 2008; Lemberger et al.,
2008; Jancic et al., 2009; Ploski et al., 2010; Ryan et al., 2011). We
found that SRF was associated with LTP, kainate, and cocaine-
mediated stimulation, whereas EGR1 was solely linked with
cocaine-mediated induction of gene expression. In contrast,
CREB was associated with most forms of activity-dependent
gene expression (Fig. 7E), consistent with the view that it acts
as a central neuronal signaling hub. FOS also appeared asso-
ciated to a variety of stimuli, although the enrichment was
consistently lower than for CREB, in agreement with the no-
tion that it is a general marker of neuronal activity down-
stream of CREB (Fig. 7F ).
CREB contribution to fsk-dependent gene expression
To define additional causal relationships between specific PRTFs
and activity-driven transcriptional programs, we focused on the
role of CREB in fsk-mediated transcription. This choice was
based on the biological relevance of CREB and cAMP signaling in
neuronal function and the very good coverage revealed in our
meta-analysis. To gain additional insight into the role of CREB in
fsk-dependent transcription, we extended the gain-of-function
analysis using caCREB with experiments using an LV that ex-
presses the inhibitor of CREB transcription, A-CREB (Ahn et al.,
1998).
A-CREB activity was assessed in HEK293 cells through
cotransfection with specific CRE-luciferase reporter plasmids
(Fig. 8A). We then proceeded to the production of the recombi-
nant pseudovirus using the same lentiviral vector used to express
the caPRTF variants (Fig. 8B). As in previous experiments,
6DINF transgenic expression was maximal without apparently
compromising cell viability (Fig. 8C).Western blots using a Flag–
M2-specific antibody confirmed the expression of the recombi-
nant protein (Fig. 8D).
To evaluate the effect of CREB inhibition on fsk-induced gene
expression, we added samples from A-CREB-infected neurons
treated with DMSO or fsk to the fsk profiling experiment and
analyzed the data with a 2 
 2 factorial design (two-way
ANOVA). Notably, we found that A-CREB by itself caused pri-
marily gene downregulations (Fig. 8E), whereas fsk, regardless of
A-CREB presence, mainly resulted in upregulations (Figs. 1B,
8E). Only one gene (Dusp1) was found in the interaction between
stimulation and infection. However, the induction profiles
clearly showed a global attenuation of fsk-induced changes in
A-CREB-expressing cultures (Fig. 8F). This effect was evident for
both upregulations and downregulations, as illustrated in the
scatter plot for fold changes in fsk-treated cultures (Fig. 8G).
In fact, 322 genes met statistical significance in the GFP–fsk
versus A-CREB–fsk comparison, most of which (74%) were
downregulated.
To further characterize this pattern, we performed k-means
clustering on fsk-regulated genes.Wedefined three clusters based
on their pattern of fsk inducibility and attenuation by A-CREB
(Fig. 8H). Cluster 1, comprising fsk-repressed genes, was es-
sentially unaffected by A-CREB in the basal condition, but the
repression by fsk was attenuated in the presence of A-CREB,
indicating that fsk-mediated downregulations are also (possi-
bly indirectly) mediated by CREB. The other two clusters cor-
responded to fsk-induced genes. Whereas cluster 2 was not or
very modestly affected by A-CREB expression, cluster 3 de-
Figure5. Time course of caCREB-dependent gene expression.A, The heatmap illustrates the differential expression of hundreds of genes during caCREB expression, both 3 and 6 d after lentiviral
infection (Inf.). The top scheme illustrates the experimental design.B, Scatter plot of the fold change correlation between transcriptional changes induced by caCREB after 3 and 6 of infection. C, Box
plot representationof average changes in thedifferent set of caCREB regulatedgenesobtainedbyk-means clustering.Onaverage, theexpressionof caCREB for 3additional days causedaverymodest
increase of the changes (both upregulations and downregulations) already observed at 3 d of infection.
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fined a group of “A-CREB attenuated” genes. We reasoned
that the genes more affected by A-CREB were more likely to be
directly downstream of CREB. In agreement with this view, we
found a specific and highly significant overlap (p  1016)
between A-CREB-attenuated and caCREB-upregulated genes
(Fig. 8 I). This intersection (81 genes) represents 63% of
A-CREB attenuated genes and 9% of caCREB-upregulated
genes, although this percentage grew steadily as we considered
stronger upregulations (Fig. 8 J). Indeed, the expression of
these 81 genes showed a good correlation between caCREB
and fsk samples, which was greatly diminished with fsk/A-
CREB samples (Fig. 8K), indicating that these genes are bona
fide target genes of CREB likely to play a role in the neuronal
response to cAMP increase (Table 3). In agreement with this
view, this group of genes scored very high in their probability
to contain a CRE site within their promoter region as pre-
dicted by PSCAN (Fig. 8L). Overall, our results indicate that
fsk-dependent transcription in hippocampal neurons is glob-
ally dependent on CREB. However, this TF is not absolutely
required for this transcriptional program because A-CREB
attenuated but did not block the changes in expression.
Discussion
This study provides a genome-wide screen of neuronal activity-
driven gene expression in response to different chemical stimuli
and downstream of four important PRTFs (CREB, SRF, EGR1,
and FOS). The use of a common approach to manipulate the
activity of different PRTFs, making their transactivation activity
Figure 6. Analysis of the CREB, SRF, EGR1, and FOS regulons. A, TF binding site prediction analysis based on the TRANSFAC database reveals a specific enrichment of the corresponding canonical
TF binding site for each TFwithin upregulatedgenes.Matrices are groupedby TF (from top tobottom: CREB_02, CREB_Q4, CREBP1_Q2, CREB_Q2, CREB_01, CREBP1CJUN_01, CREBP1_01, ATF_01,
ATF6_01, SRF_Q6, SRF_C,SRF_01, EGR3_01, EGR1_01, EGR2_01, NGFIC_01, AP1FJ_Q2, AP1_Q2, AP1_Q6. AP1_01, AP1_Q4, AP1_C). Downregulated genes do not show this enrichment. B,
Genes found upregulated by caCREB and caSRF in our study aremore likely to bind CREB and SRF, respectively, at their promoters according to a recent chromatin immunoprecipitation sequencing
experiment byKimet al. (2010). For caCREB,wepresent the average of overlap for the 3DINF and6DINFgeneprofiles. “Others” refers to the other three caPRTFs, except caCREBor caSRF, respectively.
C, The left heat map illustrates CREB-mediated upregulation of a number of miRNAs. A Fisher’s exact test was used to calculate statistical significance of the enrichment of predicted targets within
CREB-upregulated and -downregulated genes using the Miranda algorithm frommicroRNA.org (for details, see Materials and Methods). * indicates statistical significance based on an alternative
database formiRNA target predictions (Webgestalt).D, Venn diagram illustrating the overlapping genes between any given pair of conditions. The numbers in parentheses indicate the percentage
of unique genes per condition. E, The heat map of genes upregulated in at least one of the conditions show unique clusters of PRTF-induced genes (top), whereas PRTF-repressed genes are less
segregated (bottom). F, The Mammalian Phenotype Ontology was used to explore the involvement of PRTF-responsive genes in disease. Enriched categories ( p 0.01) were manually collapsed
into more general terms to avoid redundancy (see Materials and Methods). This analysis shows a general implication of the TFs CREB, SRF, EGR1, and FOS in nervous system development and
cognitive disorders.
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independent of the upstream signaling cascades that normally
would regulate it, provides an alternative and innovative way to
explore the neuronal gene programs downstream of these TFs
under highly comparable conditions. Furthermore, the integra-
tion of PRTF- and stimulation-dependent patterns through
meta-analysis has allowed us to gain novel insight into the tran-
scriptional networks underlying neuronal activity-dependent
gene expression, which is usually disregarded in single-molecule
reductionist approaches.
Our screen identified hundreds of novel stimulus-specific
activity-regulated transcripts, including novel stimulus-associated
miRNAs and candidate genes that may be differentially regulated at
Table 2. Comparative GO analysis of caPRTF-responsive gene sets
CREB SRF EGR1 FOS Functional categories 
Up Down Up Down Up Down Up Down 
Cell adhesion 
Cytoskeletal process 
Locomotion and cell motility Neuron Neural crest 
Cognition (learning and memory) 






neural crest Neuronal 
Neuronal,  
glial 
Immune response  (antigen presentation, T cell 
toxicity) 
Ion homeostasis and membrane potential 











Regulation of cell death and proliferation 
Response to stimulus Stress Drug Hormone 
Signaling pathways and transduction Neuropeptide GTPase BMP AC-PKA,  GABA 
TGFb,  
GTPase TK 
Synaptic transmission and cell communication 
Transcriptional regulation Positive Negative 
Transport and molecular localization K+, vesicle Nuclear import, Ca2+ 
Protein 
secretion, Cl- Secretion 
Shaded cells indicate significant categories ( p 0.05).When applicable, amore specific description of the representative GO terms is indicated. AC, Adenylyl cyclase; BMP, bonemorphogenic protein; GRP, G-protein-coupled receptor; PKA,
protein kinase A; TGF, transforming growth factor; TK, tyrosine kinase..
Figure 7. Contribution of PRTF-regulated gene expression to activity-dependent transcription. A, Percentages of common genes between the stimulation-driven and caPRTF-dependent gene
profiles. B, Specific coverage of activity-driven gene expression profiles by each PRTF. C, Coverage plots illustrate the dominance of CREB-mediated transcription in fsk-dependent gene expression
and the remarkable contribution of FOS to BDNF-dependent gene expression. To generate these plots, activity-upregulated genes were ordered by fold change, and the percentage of overlapping
geneswith each caPRTF-dependent gene list was calculated in a cumulativemanner. The lines therefore represent the percentage of the activity-dependent gene expression program “covered” by
each TF at any given fold change cutoff.D, Pairwise correlation analysis of stimulation- and PRTF-dependent gene expression further supports the role of CREB in fsk-mediated transcription, aswell
as the role of FOS in BDNF-mediated transcription. E, Meta-analysis of different stimulation profiles with PRTF-dependent gene expression programs reveals a dominant effect of CREB in neuronal
activity-dependent transcription, closely paralleled by FOS. SRF and EGR1, in contrast, appear to bemore specific. Normalized enrichment scores (NES) were calculated using GSEA. *p 0.05 after
false discovery rate correction. F, A graphical summary of themain relationships between CREB, SRF, EGR1, and FOS and the different paradigms of activity-driven gene expression analyzed in this
study. The line width represents the strength of the association found for the indicated interactions.
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the exon/promoter level (e.g., promoter I of the Bdnf gene and the
internal promoterwithin theCrem gene forCREB), uncoveringTF-
specific signatures and highlighting the uniqueness of the different
profiles at the functional level. We found that the changes triggered
by caCREB expression were remarkably larger, in both number and
magnitude, than for the other caPRTF. This finding together with
themeta-analysesof activity-drivengeneprogramspresented inFig-
ure 7 support a key role for CREB as a central signaling hub in the
synapse-to-nucleus transduction pathway in neurons.Our data also
suggest an important role for CREB-regulated miRNAs in activity-
dependent gene expression. Another interesting finding refers to the
effect of A-CREB on fsk-dependent gene expression. Although we
found a clear attenuation effect that demonstrates the essential role
of thisTF in the transcriptional response to fsk, the lackofacomplete
blockadeof fsk-dependent gene expressionbyA-CREBsuggests that
this TF is sufficient but not absolutely necessary for the induction of
Figure 8. Attenuation of fsk-dependent transcription by A-CREB. A, Luciferase reporter assay in HEK293 cells revealed the inhibitory effect of A-CREB expression on fsk-induced, CRE-dependent
transcription. #p 0.001, virus
 treatment effect, two-way ANOVA, F(1,26) 24.211; **p 0.01, ***p 0.001, t test.B, Lentiviral construct used for the expression of A-CREB in neurons. LTR,
Long-termination repeats; SynP, synapsin promoter; WPRE, woodchunk hepatitis virus post-transcriptional regulatory element. C, Example of GFP/A-CREB-expressing cultured hippocampal
neurons.D, Western blot showing A-CREB expression in infected neurons (10DIV, 6DINF). E, Distribution of gene expression changes induced by A-CREB expression under basal conditions (left) and
during fsk stimulation (right). F, Hierarchical cluster of GFP/A-CREB DMSO/fsk differential gene expression. G, Scatter plot showing that A-CREB expression causes an attenuation of fsk-dependent
changes. More than 70%of genes upregulated in the presence of fsk (right of the red dotted line) are below the diagonal, whereas80%of genes downregulated in the presence of fsk (left of the
red dotted line) are above the diagonal.H, k-means clustering of fsk-responsive genes revealed the existence of different profiles of fsk inducibility and A-CREB attenuation. The bold line indicates
the average profile per cluster, and the dashed line indicates the basal level (GFP DMSO); AC, A-CREB. I, A-CREB attenuated genes overlap significantlywith caCREB-upregulated genes. The 81 genes
in this intersection (red line) are listed in Table 3. There is no gene in the intersection between A-CREB attenuated genes and caCREB-downregulated genes (data not shown). J, The percentage of
CREB-responsive genes overlapping with A-CREB attenuated genes (clusters 3; for details, see Results) grows steadily as the stronger CREB-associated changes are considered. K, The genes in the
intersection between cluster 3 and caCREB-upregulated genes show a positive correlation between caCREB- and fsk-induced changes that decays in the presence of A-CREB. L, Genes in the
intersection between CREB-upregulated and A-CREB attenuated sets are likely to contain a CRE site in their promoter.
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this transcriptional program.Overall, our results suggest that, when
CREB is available, it is preferentially recruited and mediates an
important component of activity-driven gene expression with
other TFs, providing additional specificity and combinatorial
power. However, when CREB is knocked down or absent, other
TFs can compensate for this deficiency, granting a close to nor-
mal transcriptional response. Previous gene profiling experi-
ments with CREB knock-outs and A-CREB transgenic mice also
support this view (Lemberger et al., 2008; Jancic et al., 2009).
Our study also unveiled significant contributions by SRF,
EGR1, and FOS to diverse neuronal-activity driven gene expres-
sion programs, as summarized in Figure 7F. Despite their func-
tional convergence, the activity-regulated TFs CREB, SRF, FOS,
and EGR1 seem to control distinct gene expression programs
with little overlap. Regarding the transcriptional response to dif-
ferent sorts of stimuli, our analyses show that the gene programs
triggered by bic and fsk were moderately similar, probably be-
cause of common regulation through CREB-dependent tran-
scription, whereas BDNF-driven changes were more related to
caFOS-responsive genes.
Previous transcriptomics studies aimed to define the “regu-
lon” of these TFs show great disparity in their conceptual and
technical approaches, which significantly constrained compara-
bility and integration of datasets and therefore limited our insight
at themolecular systems biology level. CREB is arguably themost
intensely studied of these TFs, and great efforts have beenmade to
define its role in transcriptional regulation in neurons (McClung
and Nestler, 2003; Impey et al., 2004; Barco et al., 2005; Zhang et
al., 2005b; Lemberger et al., 2008; Jancic et al., 2009; Valor et al.,
2010). In comparison, the analysis of the neuronal regulon of
other PRTFs has received less attention. The few available studies
exploring SRF-dependent (Etkin et al., 2006; Stritt et al., 2009;
Parkitna et al., 2010) and FOS-dependent (Wu et al., 2004;
Paletzki et al., 2008) neuronal gene expression show disparate
results and limited overlap, likely because of the technical reasons
stated above. A remarkable difference between our screen and
those previous studies is the possibility to quantitatively compare
the changes triggered by the expression of each one of these
PRTFs. In addition, this study is the first one tackling the EGR1
neuronal regulon at the genome-wide level. We are, however,
aware of conceptual and technical limitations of our approach.
Table 3. Short list of CREB target genes
Gene symbol caCREB FC GFP fsk FC
GFP fsk FC/
A-CREB fsk FC Number of CRE sitesa
Nr4a2 11.08 5.03 3.37 6
Crhbp 9.26 1.94 1.17 3
Fos 6.52 6.38 2.87 9
Pcdh11x 5.55 2.19 1.15 NA
Nr4a1 5.44 6.97 3.01 6
Tinf2 5.22 1.54 0.96 4
Dusp1 5.22 4.30 1.66 2
Vgf 4.68 3.60 1.36 NA
Fosb 4.03 3.76 2.41 7
Nptx2 3.97 1.68 1.16 3
Penk 3.92 2.96 1.93 NA
Cd68 3.86 2.77 2.00 5
Ptgs2 3.83 4.18 2.43 2
Slc17a6 3.49 3.76 2.17 3
Nap1l5 3.48 2.49 1.98 NA
Cnn1 3.39 6.05 0.84 1
Tac1 3.14 2.63 1.66 3
Ecel1 3.04 1.88 1.28 4
Npy 3.04 2.03 1.17 3
Sik1 2.90 3.00 1.60 NA
Gpr3 2.90 1.68 1.25 8
Tpm4 2.88 1.95 1.49 NA
Nfil3 2.86 2.10 1.93 6
Cgref1 2.76 2.48 1.62 NA
Gadd45g 2.74 2.06 1.69 3
Emd 2.71 1.96 1.33 4
Gadd45b 2.70 1.91 1.77 3
Sik3 2.65 1.69 1.27 NA
Per1 2.60 2.25 1.84 9
Gfra1 2.53 1.96 1.44 2
Cdkn1a 2.53 2.15 1.55 3
Ptprn 2.49 2.16 1.42 5
Npas4 2.42 6.50 2.44 NA
Scg2 2.31 2.44 1.53 5
Cyfip2 2.28 2.79 1.98 1
Srxn1 2.25 2.84 1.28 NA
Sst 2.21 2.11 1.34 5
S1pr3 2.15 2.21 0.94 NA
Htr2c 2.03 2.31 1.51 6
Fn1 2.02 1.73 0.89 NA
Layn 1.97 1.87 1.24 NA
Btg2 1.90 2.52 1.81 5
Fam150b 1.86 1.94 1.79 NA
Serinc2 1.85 1.47 0.93 NA
Ostf1 1.84 1.49 0.87 NA
Ifi202b 1.82 2.52 1.59 1
Spred3 1.79 1.79 1.18 NA
Stat3 1.78 1.95 1.22 7
Nrsn1 1.78 1.69 1.25 NA
Nnat 1.77 1.70 1.11 4
Chrna1 1.76 1.99 1.29 1
Inhba 1.74 2.98 1.99 2
Ecm1 1.74 2.04 1.07 0
Ier2 1.73 1.70 1.22 4
Peg10 1.72 3.51 1.33 NA
Akap13 1.72 1.83 1.25 NA
Bag3 1.72 1.62 1.09 5
Tmbim1 1.71 1.70 1.12 NA
Cd9 1.69 1.76 0.92 2
Vim 1.69 1.98 1.01 2
Ociad2 1.67 1.90 1.20 NA
Rasgef1b 1.66 1.75 1.30 NA
Homer1 1.66 1.89 1.27 5
Gpr123 1.63 2.00 1.45 NA
(Table continues.)
Table 3. Continued
Gene symbol caCREB FC GFP fsk FC
GFP fsk FC/
A-CREB fsk FC Number of CRE sitesa
Esd 1.62 1.62 1.05 NA
Sat1 1.59 2.52 1.23 0
Ier3 1.57 2.21 1.59 3
Gadd45a 1.56 1.56 1.05 2
Tagln2 1.56 1.58 0.98 3
Fgfr2 1.54 1.77 1.29 2
Crem 1.54 1.70 0.76 1
Sgk1 1.53 2.00 1.33 NA
Synj2 1.53 1.67 1.11 4
Pvr 1.47 1.96 1.38 3
Stc1 1.46 2.74 1.29 3
Rfx4 1.44 1.66 1.00 NA
Gem 1.44 2.75 1.01 5
Plat 1.42 2.50 1.20 5
Siah3 1.41 2.30 2.19 NA
Cartpt 1.39 1.77 1.22 NA
Litaf 1.26 1.63 0.99 1
aMaximum number of CRE sites (3 kb,200 bp from TSS) according to Zhang et al. (2005). FC, Fold change; NA,
not available; TSS, transcription start site.
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Although our bioinformatic analysis indicates that our gene lists
are highly enriched for true direct targets of the different PRTFs,
we cannot exclude that unidentified downstream genes escaped
our screen because of the requirement of cofactors (e.g., JUN for
FOS or the components of SRF ternary complex). In fact, our
analyses exploring the relative contribution of each PRTF to the
different stimulation programs indicate that there must be addi-
tional TFs involved in the regulation of bic-, fsk-, and BDNF-
dependent gene expression, because we covered only40–50%
of each programwith the caPRTFdatasets. In addition, theremay
be additive or synergistic effects that our experimental approach
does not address. The analysis of additional PRTFs would likely
further increase this coverage.
The larger size of the CREB regulon suggests more abundance
of functional binding sites for this TF in the mouse genome. In
silico studies have estimated the number of CRE binding sites in
the order of tens of thousands (Euskirchen et al., 2004; Zhang et
al., 2005b), whereas for other PRTFs, binding site frequency es-
timation ranges from thousands in the case of EGR1 and FOS
(Zhou et al., 2005; Pfenning et al., 2007) to hundreds in the case of
SRF (Sun et al., 2006). However, these differences may be attrib-
utable to the use of different spans of the region upstream of the
TSS (transcription start site) in the scanning for potential binding
sites. The cisRED database for conserved regulatory elements
(Robertson et al., 2006) indicates that the number of regions in
the mouse genome containing the motifs corresponding to these
four PRTFs is similar, ranging from 3360 for CREB to 1703 for
AP-1 (FOS). Chromatin immunoprecipitation experiments sug-
gest that the effective number of CREB-occupied sites may be
lower than predicted by in silico approaches (Impey et al., 2004;
Zhang et al., 2005b). A recent study comparing occupancy in the
neuronal genome for two of the PRTF investigated here indicates
that CREB is bound to approximately twice asmany promoters as
SRF (Kim et al., 2010). Our expression data indicate that not only
may CREB have more binding sites in the genome, but it also
triggers a much broader downstream program. The common
VP16 tag included in our constitutively active chimeric proteins
enables future studies comparing the distribution and occupancy
in the neuronal genome of these four PRTFs using chromatin
immunoprecipitation sequencing technology, which would
identify their direct targets.
Overall, our study provides novel insight into the composition
of the regulon of four relevant PRTFs and their relative contribu-
tion to different activity-dependent gene expression programs.
These datasets can therefore be of great interest to researchers
working on different aspects of activity-dependent neuronal
function.
Notes
Supplemental material for this article is available at http://in.umh-
csic.es/NADtranscriptomics/. This material has not been peer reviewed.
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